medline.ch Onkologie Gynäkologische Tumoren

	The role of cellular senescence in immune-metabolic features and prognosis of ovarian cancer: an integrated analysis based on single-cell sequencing and multi-omics data. Geroscience Li Y, Bai M, Zhou Z, Wu W, Wu H, Ling S, Wang L, Zheng Y. PMID: 42228240 [PubMed - as supplied by publisher]
	Pretreatment neutrophil-to-lymphocyte ratio (NLR) as a potential risk marker for febrile neutropenia (FN) in breast and ovarian cancer during first-cycle chemotherapy. Support Care Cancer Saif F, Qureshi FN, Ahmad A, Durrani F, Azam NUA, Ullah I, Ahmed ZUD, Khan AR. PMID: 42228187 [PubMed - in process]
	Photobiomodulation for hormone therapy-induced sexual dysfunction in women with breast cancer: a prospective quasi-experimental clinical study with a parallel observational group. Support Care Cancer Vieira LR, Rezende LF. PMID: 42228167 [PubMed - in process]
	Real-World Study on the Efficacy and Safety of Incadronate Disodium in Treating Bone Metastases of Advanced Breast Cancer. Curr Pharm Des Zhu A, Gui X, Zhang R, Liang X, Shao B, Di L, Song G. PMID: 42227384 [PubMed - as supplied by publisher]
	Denosumab versus bisphosphonates for the management of bone metastases originating from breast cancer: a systematic review and meta-analysis. Future Oncol Boutros M, Awad G, Saad JP, Mitri M, Masrouha K. PMID: 42227119 [PubMed - as supplied by publisher]
	Postoperative Complications Following Neoadjuvant Therapy Across Different Oncoplastic Breast Surgery Techniques: A Retrospective Comparative Study in Breast Cancer Patients. Breast Cancer (Dove Med Press) Kulturoglu MO, Dogan L, Gulcelik MA. PMID: 42226889 [PubMed]
	Ferroptosis in breast cancer: From adipocyte-immune-iron regulation to therapeutic application. Clin Transl Med Sun J, Qu Y, Yao R, Zhou Y. PMID: 42226605 [PubMed - in process]
	Identification of Key Microbial Signatures Associated With Breast Cancer: Machine Learning-Based Approaches Using Gut Microbiome Data. Cancer Med Ahmed MT, Majumdar S, Noman AA, Alam MJ, Alam MJ. PMID: 42226580 [PubMed - in process]
	Breast cancer survival prediction using machine learning and multimodal data for personalized care plan. BMC Cancer Rady Raz N, Nafissi N, Babaee E, Fadavi P. PMID: 42226239 [PubMed - as supplied by publisher]
	Antibody-drug conjugates in breast cancer. Cancer Sakach EA, Meisel JL, McArthur HL. PMID: 42225999 [PubMed - in process]
	WeCare intervention to improve breast cancer screening and research preparedness in rural and low-socioeconomic women: study protocol for a community-engaged feasibility trial. BMJ Open Sharma P, Imsande KG, Vitriago A, Seibel M, Pritchett JC, Rudder B, Watson D, Beenken MJ, Tran LT, Larson SL, Flock C, Murphy CM, Puljas TL, Patten CA, Asiedu GB, Odedina FT, Lynch BA, Haddad TC. PMID: 42225362 [PubMed - in process]
	CRI-CCTG-0003/IND.240 an immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC): Sub-studies A and B: Durvalumab (D) + mecbotamab vedotin (BA3011) or ozuriftamab vedotin (BA3021). Cancer Treat Res Commun MacKay HJ, Tinker AV, Nelson BH, Zamarin D, Odunsi AO, Lheureux S, Ellard S, Smrke A, Gaudreau PO, Faulkner T, Upadhaya S, Zhou A, Tu W, Dancey J. PMID: 42225005 [PubMed - as supplied by publisher]
	Targeting tryptophan metabolism in breast cancer immunotherapy: Recent advances and future prospects. Transl Oncol Li G, Zhou H, Shen X, Ying P, Lu H. PMID: 42224955 [PubMed - as supplied by publisher]
	The effects of a financial navigation intervention on financial toxicity among patients with breast cancer in China: A randomized controlled trial. Breast Jing F, Yuan X, Tang Y, Liu Y, Huang Y, Chen L, Tang L, Qiu J, Xing W. PMID: 42224905 [PubMed - as supplied by publisher]
	Feasibility and Preliminary Effectiveness of the ChulaCancer Mobile Chatbot for Supportive Care of Patients With Breast or Colorectal Cancer Receiving Chemotherapy: Pilot Randomized Controlled Trial. JMIR Form Res Sompornpailin N, Susiriwatananont T, Sriuranpong V, Tanasanvimon S, Vinayanuwattikun C, Sitthideatphaiboon P, Poovorawan N, Teeyapun N, Zungsontiporn N, Pakvisal N, Panjasriprakarn P, Trakarnsanga B, Parinyanitikul N. PMID: 42224667 [PubMed - in process]
	Fovinaciclib for First-Line Therapy of Advanced Breast Cancer: A Randomized Clinical Trial. JAMA Oncol Yuan P, Liu Y, Li W, Li H, Tong Z, Cheng J, Zhang M, Shan J, Zhong J, Yi T, Liu J, Li H, Huang Z, Wu J, Ding S, Li L, Zong H, Jia H, Wang S, Wang K, Guo H, Ma L, Ouyang Z, Li H, Sun T, Lu P, Yang X, Wang X, Peng Y, Li L, Xu B, FCN-437c-III201 Investigators. PMID: 42224659 [PubMed - as supplied by publisher]
	Regulation of Glutathione Peroxidases (GPxs) in Breast Cancer: From Mechanisms to Targeted Therapeutics. J Biochem Mol Toxicol Yu H, Liao J, Zhao K. PMID: 42224423 [PubMed - indexed for MEDLINE]
	Postmastectomy radiotherapy in pN1 breast cancer: Survival outcomes and prognostic factors from a single-institution cohort. PLoS One Narasimhan RM, Saini AS, Samimi K, Ogobuiro I, Zhao X, Han S, Takita C, Taswell CS. PMID: 42224380 [PubMed - indexed for MEDLINE]
	Letter by Jiang et al Regarding Article, "Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial". Circulation Jiang B, Bao L, Ye Y. PMID: 42224374 [PubMed - in process]
	Response by Omland et al to Letter Regarding Article, "Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial". Circulation Omland T, Heck SL, Holte E, Gynnild MN, Gulati G, Wethal T. PMID: 42224372 [PubMed - in process]

Artikel 1 - 20 / 329594

Seite 1 von 16480

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung